The video highlights the COPD as a diverse disease with two main phenotypes: emphysema-predominant and bronchitis-predominant, identified through clinical expertise and CT imaging. A frequent exacerbator phenotype is associated with a rapid decline in lung function. Modern treatment approaches focus on understanding the predominant endotype, distinguished by the type of inflammation (neutrophilic or eosinophilic). Eosinophilic inflammation, characterised by a threshold of 300 cells in peripheral blood, responds well to type 2 targeted therapies, thereby improving patient outcomes.
Professor, University of Kiel, Kiel, Germany | Medical Director, Velocity Clinical Research Grosshansdorf, Grosshansdorf, Germany
See author’s profile